相关实验视频

Updated: Jan 10, 2026

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control

Published on: December 16, 2022

在压力过载的心脏中,S1PR1-MYPT1维持冠状动脉内皮壁

Xin-Yi Zhao¹, Rui Xu², Jing-Jing Li³

¹Department of Physiology and Pathophysiology, School of Basic Medical Sciences, and Key Laboratory of Environment and Genes Related to Diseases, Ministry of Education, Xi'an Jiaotong University Health Science Center, Shaanxi, China (X.-Y.Z., Y.-P.C., G.S., Z.-D.P., N.H., X.-L.D., X.-J.D., Y.Z.).

Hypertension (Dallas, Tex. : 1979)

|November 21, 2025

概括

氨酸-1-酸盐受体1型 (S1PR1) 信号传递对于在心脏压力过载期间维持冠状动脉内皮屏障功能至关重要. 破坏S1PR1-MYPT1信号传递会加剧心肌损伤和心脏重塑.

科学领域:

心血管生物学心血管生物学
内皮细胞生物学内皮细胞生物学
分子心脏病学分子心脏病学

背景情况:

冠状动脉微血管透性和炎症是压力过重引起的心肌损伤的早期迹象.
在压力过载下冠状动脉内皮屏障功能变化的作用尚未完全理解.
这项研究研究了基-1-酸盐受体1型 (S1PR1) 在压力过载期间内皮透气性中的作用.

研究的目的:

阐明S1PR1在压力过载下冠状动脉内皮透气性中的特定作用.
为了确定心脏内皮细胞中S1PR1调节的信号通路.
探索针对心脏病中的S1PR1-MYPT1信号传导的治疗潜力.

主要方法:

使用具有内皮特异性缺失S1PR1或MYPT1的小鼠模型,经过横向大动脉收缩.
使用培养的人类静脉内皮细胞 (ECs) 进行体外实验.
分析了S1PR1表达,MYPT1酸化和下游信号通路.

主要成果:

内皮S1PR1在压力过载后升级调节;其缺失导致过度透性,胀和炎症.
在EC中S1PR1缺乏改变了MYPT1酸化和增加了TRPV4表达,导致流入.
内皮MYPT1缺陷也导致过性,S1PR1激动剂治疗是无效的.
缺少S1PR1和MYPT1的小鼠在压力过载后表现出恶化的心脏重塑.

结论:

在压力过载下,S1PR1-MYPT1信号轴对于维持冠状动脉内皮透气性和心肌平衡至关重要.
针对这种途径可能为压力过载引起的心脏病提供一种新的治疗策略.
了解内皮屏障调节对于预防心脏损伤和心脏重塑至关重要.

关键词:

这是一种炎症炎症炎症炎症.微血管透性微血管透性肌素轻链细胞质.斯芬戈-1-酸盐受体 1 种腹腔的重塑腹腔的重塑

更多相关视频

Isolation of Endocardial and Coronary Endothelial Cells from the Ventricular Free Wall of the Rat Heart

Isolation of Endocardial and Coronary Endothelial Cells from the Ventricular Free Wall of the Rat Heart

Published on: April 15, 2020

Surgical Placement of Catheters for Long-term Cardiovascular Exercise Testing in Swine

Surgical Placement of Catheters for Long-term Cardiovascular Exercise Testing in Swine

Published on: February 9, 2016

相关概念视频

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...

Heart Failure II: Pathophysiology

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...

Physiology of the Heart: The Cardiac Cycle

Physiology of the Heart: The Cardiac Cycle

The cardiac cycle describes the events from one heartbeat to the next. It includes three main phases: diastole, atrial systole, and ventricular systole, all driven by changes in chamber pressures and the function of heart valves.
Diastole: The Relaxation Phase
During diastole, all four heart chambers relax. The atrioventricular (AV) valves open, and the semilunar valves close. This phase sees the lowest chamber pressures, promoting ventricular filling. Venous blood enters the heart through the...